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The G-protein coupled receptor GPR54 and its ligand, KiSS-
1-derived peptide kisspeptin-54, appear to play an important
role in the mechanism of puberty. This study measures the
release of kisspeptin-54 in the stalk-median eminence (S-ME)
duringpuberty and examines its potential role in the pubertal
increase in LHRH-1 release in female rhesus monkeys. First,
developmental changes in release of kisspeptin-54 and LHRH-1
were assessed in push-pull perfusate samples obtained from
the S-ME of prepubertal, early pubertal, and midpubertal fe-
male rhesus monkeys. Whereas LHRH-1 levels in 10-min in-
tervals had been measured previously for other experiments,
kisspeptin-54 levels in 40-min pooled samples were newly
measured by RIA. The results indicate that a significant in-
crease in kisspeptin-54 release occurred in association with
the pubertal increase in LHRH-1 release and that a nocturnal
increase in kisspeptin-54 releasewas already observed in pre-
pubertal monkeys and continued through the pubertal period.
Second, we measured kisspeptin-54 release in the S-ME of mid-
pubertal monkeys at 10-min intervals using a microdialysis
method. Kisspeptin-54 release in the S-MEwas clearly pulsatile
with an interpulse interval of about 60 min, and approximately
75%ofkisspeptin-54pulseswerecorrelatedwithLHRH-1pulses.
Finally, the effect of kisspeptin-10 on LHRH-1 release was ex-
amined with the microdialysis method. Kisspeptin-10 infusion
through amicrodialysis probe significantly stimulated LHRH-1
release inadose-dependentmanner.Collectively, theresultsare
consistent with the hypothesis that kisspeptin plays a role in
puberty. (Endocrinology 149: 4151–4157, 2008)
BECAUSE A DELAY in or absence of puberty in patientswithmutations in the gene encodingGprotein coupled
receptor 54 (GPR54) has been reported (1–3), GPR54 and its
cognate ligand, kisspeptin-54 (also called metastin1–54),
have been proposed to play a significant role in the mech-
anism of the onset of puberty (4–8). GPR54 is a member of
theGprotein-coupled seven-transmembrane receptor family
and the metastasis suppressor gene KiSS-1-derived peptide,
kisspeptin-54, is its ligand (9–11). The C-terminal region of
kisspeptin-54 is responsible for receptor binding, and short
forms of the peptide, kisspeptin-10, -13, -14, and -15, are all
biologically active (9–11). Moreover, LHRH-1 neurons ex-
press GPR54 (12, 13), and kisspeptins stimulate LH and
FSH release (13, 14–16). Hypothalamic expression of KiSS
mRNA increases with puberty (13, 14), and GPR54 mRNA
expression increases with puberty (14). Importantly, mice
lacking the GPR54 gene failed to undergo puberty and had
immature gonads (1, 17). Recently, it has been reported
that mice lacking the KiSS-1 gene also exhibited abnormal
timing of puberty, although their phenotypes were not as
severe as those in GPR54 knockout mice (18, 19). These
reports are consistent with the hypothesis that the GPR54
and KiSS-1 genes are responsible for the onset of puberty.
Nonetheless, to support this hypothesis, several critical
questions remain to be answered. Is kisspeptin-54 release
in the stalk-median eminence (S-ME) pulsatile? Does kisspep-
tin-54 release in the S-ME change at puberty? Do kisspeptins
stimulate LHRH-1 release in vivo in primates? To answer to
these questions, we conducted the present study. We found
that kisspeptin-54 was released in a pulsatile manner in the
S-ME, kisspeptin-10 stimulated LHRH-1 release, and
kisspeptin-54 release increased along with the pubertal in-
crease in LHRH-1 release.
Materials and Methods
Animals
All animals used in this study were born and raised in the Wisconsin
National Primate Research Center. They were housed in pairs (cages
172  86  86 cm) in rooms with 12 h light (0600–1800 h)and 12 h dark
(1800–0600 h), except for experiments 2 and 3, and controlled temper-
ature (22 C). During the entire course of experiments 2 and 3, the animals
were kept in a room where the lighting condition was shifted to lights
on from 0300–1500 h and lights off from 1500–0300 h. The animals were
fed a standard diet of Harlan 20% Protein Primate Diet once every
morning, supplemented with fresh fruit several times per week. Water
was available ad libitum. The protocol for this study was reviewed and
approved by the Animal Care and Use Committee, University of
Wisconsin, and all experiments were conducted under the guidelines
established by the National Institutes of Health and U.S. Department
of Agriculture.
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Experiment 1: developmental changes in release of
kisspeptin-54 and LHRH-1 in the S-ME
In the first experiment, we asked whether kisspeptin-54 is detectable
in samples collected from the S-ME of female rhesus monkeys and, if so,
whether developmental changes in kisspeptin-54 release occur along
with the pubertal increase in LHRH-1 release. Two sets of push-pull
perfusates, which were collected from female rhesus monkeys at the
three stages of puberty using the push-pull perfusionmethodwere used.
LHRH-1 levels in the perfusates had beenmeasured previously for other
studies. The first set of samples were collected at 0900–1100 h from 10
prepubertal, eight early pubertal, and nine midpubertal females at
17.2  0.4, 23.0  1.0, and 38.3  2.0 months of age, respectively, at
10-min intervals using the push-pull perfusion method. The body
weights of these animals were 2.3  0.1, 3.1  0.1, and 5.0  0.4 kg,
respectively. The second set of samples were collected at 0600–1200 h
and 1800–2400 h from six prepubertal, six early pubertal, and five
midpubertal females at 16.6  1.3, 24.5  1.1, and 38.7  2.2 months of
age, respectively, at 10-min intervals using the push-pull perfusion
method. Their body weights were 2.4  0.2, 3.4  0.3, and 4.7  0.3 kg,
respectively. The pubertal stages were defined as described previously
(20). Because of a small sample volume left after LHRH-1 assay, four
consecutive (a 40-min period) samples were pooled for kisspeptin-54
assay. For comparison, mean LHRH-1 levels during the corresponding
40-min period measured previously were calculated from four succes-
sive 10-min values. Because surgical procedures and the push-pull per-
fusion method have been extensively reported (21, 22), we will not
describe them in this article.
Experiment 2: release pattern of kisspeptin-54 in the S-ME
Because we found that kisspeptin-54 was released in the S-ME from
experiment 1, in the second experiment, we examined whether kisspep-
tin-54 is released in a pulsatile manner using the microdialysis method.
Four female rhesus monkeys at 29.1  1.2 months of age (body weight
3.6  0.1 kg) received cranial pedestal implantation as described pre-
viously (22). A custom-made microdialysis probe with a polyarylether-
sulfone membrane (CMA 12; CMA, Stockholm, Sweden) was inserted
into the S-ME, and dialysates for kisspeptin-54 assay were collected at
10-min intervals for up to 12 h. Kisspeptin-54 levels in dialysates were
assessed by a specific RIA (16). Each animal was examined one to three
times. Themean age of samplingwas 34.8 1.2months. This experiment
was conducted in a roomwith lights on from 0300–1500 h and lights off
from 1500–0300 h.
Experiment 3: the effect of kisspeptin-10 infusion into the
S-ME on LHRH-1 release
In the third experiment, we tested whether human kisspeptin-10
[Kiss-1 (112–121)-amide; Phoenix, Belmont, CA] infusion into the S-ME
induced LHRH-1 release using themicrodialysis method. The same four
midpubertal females were used for this experiment. Human kisspep-
tin-10 at 0.1, 1, and 10 nm dissolved in central nervous system perfusion
fluid by CMA (see below) or vehicle alone was infused through the
microdialysis probe for 10 min in a random order, whereas dialysates
were continuously collected. Each animalwas examined repeatedlywith
two to three doses up to three times. LHRH-1 levels in dialysates were
assessed by RIA. This experiment was also conducted in a room with
lights on from 0300–1500 h and lights off from 1500–0300 h.
Microdialysis experiments
Implantation of cranial pedestal. Before experiments, monkeys were well
adapted to the primate chair, the experimental environment, and the
investigator, as described previously (20, 21). Theywere implantedwith
a cranial pedestal under isoflurane anesthesia, similar to those described
previously for push-pull perfusion method (20, 21). Animals were al-
lowed to recover for at least 1 month before experimentation.
Insertion of a guide cannula and a microdialysis probe. On the day of ex-
periment, the monkey was placed in the stereotaxic apparatus under
ketamine (15mg/kg bodyweight) andmedetomidine (0.03–0.05mg/kg
body weight) anesthesia. The custom-made guide cannula (CMA 12)
consisted of a stainless steel shaft (76.0 mm in length, 0.91 mm outer
diameter) and a removable stainless steel stylet (96.0 mm in length, 0.6
mm outer diameter), which extruded 20mm from the guide cannula tip.
It was inserted into the skull 5 mm above the S-ME with a hydraulic
microdrive unit (MO95-B; Narshige, Tokyo, Japan). The microdrive unit
allowed for accurate three-dimensional adjustment of the tip location.
The x, y, and z coordinates for the S-ME were calculated using ven-
triculographs and the final radiographs taken during cranial pedestal
implantation surgery. Cannula placement was confirmed with radio-
graphic visualization, as described previously (22, 23). After placement
of the guide cannula, the monkey was removed from the stereotaxic
apparatus and placed into a primate chair. Once the monkey was prop-
erly placed in the chair, the inner stylet was removed from the guide
cannula, and the custom-made microdialysis probe (a stainless steel
shaft 96.0mm in length, 0.6mmouter diameter), fittedwith amembrane
(5 mm in length, 0.5 mm outer diameter), was inserted into the S-ME
through the guide cannula as described previously (23). To reverse the
effects of medetomidine, atipamazole (0.15–0.25 mg/kg) was injected
(iv) into the animal. The animal was fully awake within 1 h after probe
insertion.
In vivo microdialysis perfusion. A perfusion fluid consisting of 147 mm
NaCl, 2.7 mm KCl, 1.2 mm CaCl2, and 0.85 mm MgCl2, purchased from
CMA/Microdialysis with bacitracin (4 U/ml) added, was infused
through the inflow tubing at 2 l/min with the CMA/102 microdialysis
pump (Stockholm, Sweden) outfitted with a 1- or 2.5-ml Hamilton gas
tight syringe (Reno, NV). Perfusates were continuously collected at
10-min intervals for up to 12 h through the outflow tubing into 12- 
75-mm borosilicate tubes containing 280 l RIA buffer (solution con-
taining 0.1% gelatin in 0.01 m PO4; 0.15 m NaCl; 0.1% NaN3, pH 7.4) on
ice with a fraction collector (model FC203B; Gilson, Middleton, WI). The
perfusate samples were immediately frozen on dry ice and stored at
80 C. During the entire experiment, monkeys were placed in prox-
imity to a companion monkey, given constant access to food and
water, and were provided frequently with fruit, cereal, raisins, and
other snacks.
RIAs for kisspeptin-54 and LHRH-1
Kisspeptin-54 in 150l frompooled push-pull perfusates (experiment
1) or 20 l from microdialysates (experiment 2) were measured by RIA
using antiserum GQ2, as described previously (16). Briefly, GQ2 was
raised in a sheep immunized with synthetic human kisspeptin-54 con-
jugated to BSA by glutaraldehyde. This antisera cross-reacts 100% with
human kisspeptin-54, kisspeptin-14, and kisspeptin-10. Although this
antibody does not discriminate kisspeptin-54 from smaller kisspeptin
molecules, we used kisspeptin-54 throughout the article, because cur-
rently kisspeptin-54 is the only known peptide form for the GPR54
ligand in human circulation (24). GQ2 cross-reacts less than 0.01% with
any other related human RFamide peptide, including human RFamide-
related peptide (RFRP)1, human RFRP2, human RFRP3, prolactin-re-
leasing peptide, human neuropeptide FF, and human neuropeptide AF
as well as LHRH-1 (16). It is important to emphasize that GQ2 was not
cross-reactive with human RFRP1 and RFRP3, which are also known to
be gonadotropin-inhibiting hormones in the avian (25). Synthetic human
kisspeptin-54 [Kiss-1 (68–121)-amide; Bachem, Torrance, CA] was used
for both radiolabeled antigen and the reference standard. A custom-
ordered [125I]kisspeptin-54 was produced by Bachem. The antigen-an-
tibody complex was precipitated with a donkey antisheep--globulin.
The sensitivity was 0.05 pg/tube at a 95% confidence limit, and intra-
and interassay coefficients of variation were 10.1 and 14.3%, respec-
tively. We also confirmed that neither artificial cerebrospinal fluid used
for push-pull perfusion nor perfusion fluid used for microdialysis in-
terferes with the kisspeptin-54 assay. LHRH-1 RIA was conducted with
antisera, either R42 or R1245, kindly provided by Dr. Terry Nett (Col-
orado State University, Fort Collins, CO), as described previously (21).
Assay sensitivitywas 0.02 pg/tube, and intra- and interassay coefficients
of variation were 8.1 and 11.3%, respectively. For co-measurement of
kisspeptin-54 and LHRH-1 (experiment 2), 20-l microdialysates were
divided into two aliquots (10 l each).
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Statistical analysis
Developmental changes in kisspeptin-54 release (experiment 1) were
evaluated with two-way ANOVA unrepeated measure followed by
Tukey’s multiple comparison test.
Peaks of kisspeptin-54 in dialysates (experiment 2) were identified
using the PULSAR algorithm (26). Intraassay coefficents of variation for
kisspeptin-54 assay were described by the equation y  0.0491x2
0.1726x 0.1813. The cutoff criteria for pulse determination, G1, G2, G3,
G4, and G5 were 3.8, 2.6, 1.9, 1.5, and 1.2, respectively. Parameters of
pulsatile kisspeptin-54 release were calculated for each experiment as
follows: 1) mean kisspeptin-54 release was derived from the mean of all
kisspeptin-54 values; 2) pulse amplitude of kisspeptin-54 release was
defined as the difference between peak and trough; 3) interpulse interval
was defined as the intervals between peaks of kisspeptin-54 pulses; and
4) total release was calculated by adding the kisspeptin-54 values of a
given period. Subsequently, mean  sem for each parameter was cal-
culated. The difference in the mean, pulse amplitude, and total release
between the lights-on period and lights-off period were examined by
paired t test. Correlation between kisspeptin and LHRH-1 pulses was
determined by a method described previously (27, 28). Because we
expect that kisspeptin stimulates LHRH-1 release in the hypothalamus,
with this method, kisspeptin pulses were considered to be correlated
with LHRH-1 pulses if a kisspeptin peak occurred at the same time as
or 10min preceding a LHRH-1 peak. As a control, a set of kisspeptin data
from a monkey was cross-compared with a set of mismatched LHRH-1
data from another monkey. Subsequently, the frequency of coincidence
from the experiment in which kisspeptin and LHRH-1 were measured
in the same sample was compared with the frequency of random co-
incidence from a mismatched data set. Statistical significance was eval-
uated with Student’s t test.
The effect of kisspeptin-10 on LHRH-1 release (experiment 3) was
examined by comparing the two points before and after kisspeptin (or
vehicle) challenge using two-way ANOVA (variables: treatment and
dose) followed by Tukey’s multiple comparison test. Because each trial
had a different combination of kisspeptin doses, we treated each ex-
periment as one entry. If the same dose was tested twice in an exper-
iment, the mean of the two was used as an entry. No animal contributed
more than twice in each dose. All statistical analyses were conducted
with raw values. Differences were considered significant at P  0.05.
Results
Experiment 1: developmental changes in release of
kisspeptin-54 and LHRH-1 in the S-ME
The first set of samples collected from prepubertal, early
pubertal, and midpubertal monkeys contained 0.36  0.09,
0.70  0.19, and 1.00  0.15 pg/ml kisspeptin-54, respec-
tively. Previously measured LHRH-1 levels in the corre-
sponding samples were 1.51  0.51, 3.66  0.99, and 5.57 
1.88 pg/ml, respectively. Statistical analysis indicated that
kisspeptin-54 concentrations in the midpubertal monkeys
were significantly higher (P 0.01) than those in prepubertal
monkeys, and LHRH-1 concentrations in the midpubertal
and early pubertal monkeys were significantly higher (P 
0.05) than those in prepubertal monkeys.
To confirm the initial findings described above and to
further examine whether a nocturnal increase in kisspep-
tin-54 release occurs in association with the nocturnal in-
crease in LHRH-1 release during puberty, we measured
kisspeptin-54 in push-pull perfusates obtained in the morn-
ing (0600–1200 h) and evening (1800–2400 h). Kisspeptin-54
levels in 40-min pooled samples showed that both morning
and evening levels significantly (P  0.01 for morning, P 
0.05 for evening) increased during the course of puberty
(Fig. 1). Post hoc analysis further indicated that morning
levels in early pubertal monkeys were significantly higher
than those in prepubertal monkeys, and both morning and
evening levels of midpubertal monkeys were also signif-
icantly higher than those in prepubertal and early pubertal
monkeys (Fig. 1). In addition, the nocturnal increase in
kisspeptin-54 release was already observed in prepubertal
monkeys and continued through the pubertal period.
LHRH-1 levels during the corresponding 40-min period
indicated that both morning and evening levels significantly
(P  0.001 for both morning and evening) increased during
the course of puberty. Post hoc analysis indicated that both
morning and evening levels in midpubertal monkeys were
significantly higher than those in prepubertal and early pu-
bertal monkeys, and evening levels in early pubertal mon-
keys were significantly higher than those in prepubertal
monkeys. The nocturnal increase in LHRH-1 release was
observed in early and midpubertal monkeys but not in pre-
pubertal monkeys.
Experiment 2: release pattern of kisspeptin-54 in the S-ME
Changes in kisspeptin-54 levels in the S-ME measured by
the microdialysis method suggested that kisspeptin-54 re-
FIG. 1. Developmental changes in the release of LHRH-1 (top) and
kisspeptin-54 (bottom) in push-pull perfusates. Both peptides were
measured in the same samples. Kisspeptin-54 levels gradually in-
creased along with the pubertal increase in LHRH-1 release. The
nocturnal increase in kisspeptin-54 release was already observed in
prepubertal monkeys and continued through the pubertal period. In
contrast, the nocturnal increase in LHRH-1 release occurred in early
andmidpubertal monkeys but not in prepubertal monkeys. The num-
ber of animals at the prepubertal, early pubertal, and midpubertal
stages was six, six, and five, respectively.White bars, morning values;
black bars, evening values. *, P 0.05 vs. prepubertal; ***, P 0.001
vs. prepubertal;, P 0.05 vs. early pubertal;, P 0.01 vs. early
pubertal;, P 0.001 vs. early pubertal; a, P 0.05 vs.morning;
aa, P  0.01 vs. morning; aaa, P  0.001 vs. morning.
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lease was clearly pulsatile (Fig. 2). Pulse interval, mean re-
lease, and pulse amplitude were 59.3  14.8 min, 2.1  0.3
pg/ml, and 3.8 1.0 pg/ml, respectively (n 7). Moreover,
interpulse interval (59.3  14.8 min) of kisspeptin-54 release
in midpubertal females was similar to that (55.8  10.9 min)
of LHRH-1 release obtained from adult ovariectomized fe-
males with the microdialysis method (Table 1; Ref. 23). Im-
portantly, kisspeptin-54 levels, increased shortly after lights-
off (Fig. 2, A and B). Statistical analysis indicated that total
release of kisspeptin-54 (68.0  16.6 pg/ml) during the 5-h
period after lights-offwas significantly (P 0.05) higher than
that (30.1  6.9 pg/ml) during the 5-h period before lights-
off. Bothmean release (2.9 0.5 pg/ml) and pulse amplitude
(5.0  1.4 pg/ml) during the dark phase had a tendency to
be higher than those during the light phase (1.8  0.3 and
2.7 0.5 pg/ml, respectively), although the values were not
statistically significant (P  0.05).
To assess the coordinated release of LHRH-1 and kisspep-
tin-54, we measured kisspeptin-54 and LHRH-1 in the same
samples. As shown in Fig. 2C, data suggested that kisspep-
tin-54 and LHRH-1 pulses had a tendency to occur with a
similar timing. Statistical analysis indicated that kisspep-
tin-54 peaks occurred at the same time as or 10 min before
LHRH-1 peaks 76.5  2.4% of the time (n  3), and this
coincidence was significantly higher (P 0.02) than random
coincidence (45.4  6.6%, n  3).
Experiment 3: the effect of kisspeptin-10 infusion into the
S-ME on LHRH-1 release
Next we examined whether human kisspeptin-10 stim-
ulated LHRH-1 release using the microdialysis method.
Kisspeptin-10 at 1 and 10 nm infusion through a micro-
dialysis probe consistently stimulated LHRH-1 release,
whereas kisspeptin-10 at 0.1 nm stimulated LHRH-1 release
in most of the cases (four of five cases, Fig. 3). Statistical
analysis suggested that there was a significant interaction
between treatment and dose (P 0.01), and the kisspeptin-10
induced LHRH-1 release was a dose dependent (P  0.01,
Fig. 4). Post hoc analysis indicated that kisspeptin-10 at doses
of 1 and 10 nm resulted in a significant increase in LHRH-1
release (P  0.01 and P  0.05, respectively), whereas the
LHRH-1 response to kisspeptin-10 at 0.1 nm was not signif-
icant. Based on our previous assessment that the dialysis
membrane passes about 10% of the peptide (23), it is esti-
mated that the threshold concentration of kisspeptin-10 to
induce LHRH-1 release in the S-ME was 0.1 nm.
Discussion
The results of the present study suggest that 1) a sig-
nificant increase in kisspeptin-54 release occurred in as-
sociation with the pubertal increase in LHRH-1 release; 2)
a nocturnal increase in kisspeptin-54 release was already
observed in prepubertal monkeys and continued through
the pubertal period, whereas a nocturnal increase in
LHRH-1 release occurred in early pubertal andmidpubertal
but not in prepubertal monkeys; 3) kisspeptin-54 release in
FIG. 2. Kisspeptin-54 release in the S-ME assessed by the microdi-
alysis method was pulsatile. In A and B, kisspeptin-54 alone was
measured in microdialysate samples, whereas in C, both kisspep-
tin-54 (F) and LHRH-1 (E) weremeasured in the samemicrodialysate
samples. Kisspeptin-54 and LHRH-1 pulses, indicated by asterisks,
were identified using the PULSAR algorithm. Kisspeptin-54 pulses
correlated with LHRH-1 pulses, defined in Materials and Methods,
are indicated by arrows on the top of kisspeptin pulses. Lighting
conditions are indicated on the top of each graph (white bar for the
lights-on period and black bar for the lights-off period). Note that in
all three cases, total release of kisspeptin-54 during a 5-h period of the
dark phase was significantly higher than that during the light phase.
Themissing data between 370 and 390min inAwas due to a technical
problem during the sample collection.
TABLE 1. Comparison of kisspeptin-54 release and LHRH-1
release measured by microdialysis in female rhesus monkeys
Kisspeptin-54 LHRH-1a
Mean (pg/ml) 2.1  0.3 9.9  3.9
Baseline (pg/ml) 1.1  0.1 3.8  2.1
Amplitude (pg/ml) 3.8  1.0 10.6  4.3
Interpulse interval (min) 59.3  14.8 55.8  10.9
n 7 4
Results are shown as mean  SEM.
a From ovariectomized adult females (23).
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the S-ME is pulsatile with an interpulse interval of about 60
min and about 75% of kisspeptin-54 pulses occurred with
LHRH-1 pulses; and 4) kisspeptin-10 stimulates LHRH-1
release in a dose-dependent manner.
An increased release in LHRH-1 from the hypothalamus
is essential for the onset of puberty. Pulsatile administration
of LHRH-1 induces menarche and first ovulation in sexually
immature female monkeys (29), and an increase in LHRH-1
release in the S-ME occurs at the onset of puberty in female
monkeys (20). However, the mechanism triggering the pu-
bertal increase in LHRH-1 release is still unclear (30). It has
been hypothesized that activation of the GPR54 signaling
mechanism plays an important role in the onset of puberty.
1) Hypothalamic expression of both GPR54 and KiSS-1
mRNA are significantly elevated around the time of puberty
in male and female rats (14) and in ovarian intact pubertal
female monkeys (13). 2) The number of LHRH-1 neurons
responding to kisspeptin-10 increases with developmental
age in mice, and LH response to intracerebroventricular in-
jection of kisspeptin in juvenile mice is higher than in adult
mice (31). 3) The number of kisspeptin-positive neurons in
the anteroventral periventricular nucleus ofmice increases at
the age of puberty (32). 4) Central administration of kisspep-
tin results in precocious puberty in female rats (33) and
precocious LH elevation in prepubertal male monkeys (34).
Therefore, if this hypothesis is correct, kisspeptin release
would increase along with the pubertal increase in LHRH-1
release. In the present study, we measured kisspeptin-54
levels in two sets of our archived samples, which were pre-
viously collected from the S-ME of prepubertal, early pu-
bertal, and midpubertal monkeys using a push-pull perfu-
sionmethod, fromwhich we had alreadymeasured LHRH-1
several years ago. In the first set of samples obtained during
the morning (0900–1100 h), kisspeptin-54 levels increased
with the developmental increase in LHRH-1 release. In the
second set of samples, we were able to assess kisspeptin-54
levels in samples collected both during the morning (0600-
1200 h) and evening (1800–2400 h). To our surprise,
kisspeptin-54 levels not only gradually increased during
the progress of puberty in parallel with the pubertal increase
in LHRH-1 release, but kisspeptin-54 levels during the
evening were also higher than in the morning in animals at
all developmental stages, i.e. prepubertal and early andmid-
pubertal stages. Although additional studies are required,
these observations are indicative for the role of kisspeptin in
puberty.
Because we needed to pool archived samples for kisspep-
tin-54 assay,wewere not able to assess the pattern of kisspep-
tin-54 release in the S-ME. Thus, we conducted experiment
2 with themicrodialysis method. Kisspeptin-54 release in the
S-ME in midpubertal monkeys was pulsatile with an inter-
pulse interval of about 60 min, which is very similar to that
of LHRH-1 release in ovariectomized adult female monkeys.
Interestingly, kisspeptin-54 release increased shortly after
the lights went off. At this point, it is unclear whether this
phenomenon is unique to only midpubertal monkeys or all
other developmental stages, i.e. neonatal, prepubertal (juve-
nile), early pubertal, and fully mature stages. It is further
unclear whether the kisspeptin-54 response to the lights-off
signal is a simple reflex of kisspeptin neurons to optic input
or a part of entrained circadian rhythms of kisspeptin neu-
rons. Nonetheless, these observations from experiment 2
along with the nocturnal increase in kisspeptin-54 release
from experiment 1 suggest that the prominent nocturnal
increase in LHRH-1 release in pubertal monkeys (20, 35)
might be attributable to the LHRH-1 neuronal system being
directly coupled to the light-sensitive kisspeptin neuronal
system.
A significant number of studies show that central or sys-
temic administration of kisspeptin stimulates LH release in
FIG. 4. Kisspeptin-10 infusion to the S-ME induced LHRH-1 release
in a dose-responsive manner. The kisspeptin-10-induced LHRH-1
responses are expressed as a percentage of before kisspeptin-10 chal-
lenge. The overall dose-response curve was significant at P 0.01. **,
P  0.01 vs. baseline before kisspeptin-10 in each dose; a, P  0.05
vs. vehicle; b, P  0.05 vs. 0.1 nM; c, P  0.05 vs. 1 nM. n  5 in all
groups.
FIG. 3. An example of the effects of human kisspeptin-10 on LHRH-1
release in a pubertal female monkey. Kisspeptin-10 at 10 or 0.1 nM
concentration or vehicle was perfused through a dialysis membrane
(as indicated by a shaded bar), and LHRH-1 levels in dialysates
obtained from the S-ME were measured by RIA. Note that the local
concentration of kisspeptin-10 in the tissue was estimated to be 1 or
0.01 nM, respectively, based on a 10% recovery rate through the
membrane. Kisspeptin-10 stimulated LHRH-1 release.
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a dose-dependent manner in vivo in various species includ-
ing in humans [1, 12, 13, 16, 36; see also review by Seminara
(6)] and LHRH-1 release in vitro (37). In experiment 3, we
observed that kisspeptin-10 stimulated LHRH-1 release in a
dose-dependentmanner in vivo. To our knowledge, this is the
first report of direct evidence showing that kisspeptin-10
administered locally into the S-ME stimulates LHRH-1 re-
lease in animals in vivo. Based on the similar pulse frequency
of kisspeptin-54 release and LHRH-1 release in experiment
2 and the ability of kisspeptin-10 to stimulate LHRH-1
release in a dose-dependent manner, we can hypothesize
that pulsatile kisspeptin-54 release is associated with pul-
satile LHRH-1 release. Indeed, our data shown in Fig. 2C
suggest that approximately 75% of kisspeptin-54 peaks
occurred at the same time as or 10 min preceding thr
LHRH-1 peaks, although the correlation between kisspep-
tin-54 and LHRH-1 pulses was not as tight as we have seen
between neuropeptide Y and LHRH-1 pulses (27).
The pubertal increase in LHRH-1 release is independent
from the pubertal increase in the ovarian steroid estrogen,
because the pubertal increase in LHRH-1 release is observed
in ovariectomized females (35) and estrogen suppresses
LHRH-1 release after, not before, the onset of puberty (38).
However, the question of whether the increase in kisspep-
tin-54 release with female puberty observed in this study is
due to the pubertal increase in circulating estrogen or de-
velopmental change in the hypothalamus remains to be in-
vestigated. For example, whereas the influence of gonadal
steroids on kisspeptin gene expression has extensively been
reported (4–8, 39), the data by Shahab et al. (13) that the
pubertal increase in KiSS-1 mRNA, but not GPR54 mRNA,
expression was observed in gonadectomized male monkeys,
indicating that the gonadal steroid-independent matura-
tional change in the GPR54 signaling system occurs in male
monkeys. However, in that study (13), the authors did not
examine whether the developmental increase in KiSS-1
mRNA levels was independent from the pubertal increase in
gonadal steroid, estrogen, in female monkeys. Because there
are some sex differences in the mechanism of the onset of
puberty in primates (30, 40, 41), it will be important to in-
vestigate the possible role of estrogen in the pubertal increase
in kisspeptin-54 release in the future.
In our previous and present studies, we did not observe a
nocturnal increase in LHRH-1 release in prepubertal mon-
keys (30), although a nocturnal increase in LH (and presum-
ably LHRH-1) has been described in prepubertal children
(41).Nonetheless, our observation that the nocturnal increase
in kisspeptin-54 precedes the nocturnal increase in LHRH-1
release is consistentwith the hypothesis that kisspeptin plays
a role in the mechanism of the onset of puberty, and our
findings lead to several important questions. How much of
a role does kisspeptin/GPR54 signaling play in the timing of
puberty? Does an increase in kisspeptin release trigger the
pubertal increase in LHRH increase? Does a decrease in
prepubertal -aminobutyric acid (GABA) inhibition precede
the pubertal increase in kisspeptin release, or does the pu-
bertal increase in kisspeptin release trigger GABA disinhi-
bition before the onset of puberty?Does the pubertal increase
in glutamate release coincide with kisspeptin increase? We
need answers to these questions before establishing the crit-
ical role of kisspeptin in puberty, because previously we
found that a decrease in GABAergic inhibition followed by
an increase in glutamatergic stimulation is critical for the
onset of puberty (30).
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